We are pleased to announce that our President has been honored with the 2025 Volunteer of the Year Award by Hope for Dementia. This recognition reflects his outstanding dedication, leadership, and commitment to serving others.
New year, same mission — just a little less stress? 🥂
You know that feeling when you’ve just completed a massive project, validation is complete, and you’re ready to ship product? That sweet relief is immediately followed by the cold dread of realizing the FDA Pre-Approval Inspection (PAI) is looming…
In aseptic manufacturing, the PAI isn’t just an inspection -it’s the regulatory World Series, the Aseptic Olympics- success demands a flawless routine without dropping any SOPs. The medal is market access; the judge is the FDA.
The transition to the revised EU GMP Annex 1 (2022) demands a shift from simply building a clean space to engineering a comprehensive Contamination Control Strategy (CCS). Validation issues are often rooted in the design phase, where planning assumptions misalign with operational reality.
If your facility design does not thoroughly address risks associated with operator interventions or material and equipment transfer to sterile areas, you are potentially compromising your sterility assurance.
Welcome to the GPharma Solutions blog!
Here we will be posting current goings-on with the company in addition to informative posts regarding subjects relevant to the services we provide. You may easily find posts based on the category of post and/or tags indicating its subject!
This blog also supports RSS. If you wish to take advantage of this, use the following link: https://gpharmasolutions.com/blog/index.xml
More to come soon. Stay tuned!
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template par Bootstrapious. Porté sur Hugo par DevCows.
